CARGO Therapeutics, Inc. Common Stock
CRGX · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$49,937 | -$84,498 | -$45,435 | -$41,908 |
| Dep. & Amort. | $572 | $1,220 | $1,363 | $1,796 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $5,258 | $6,876 | $4,835 | $4,931 |
| Change in WC | -$35,562 | $31,610 | $3,603 | -$6,282 |
| Other Non-Cash | $2,285 | $7,099 | $747 | $1,838 |
| Operating Cash Flow | -$77,384 | -$37,693 | -$34,887 | -$39,625 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$99 | -$382 | -$630 | -$735 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | -$81,687 | -$115,413 | -$133,312 |
| Inv. Sales/Matur. | $124,462 | $117,294 | $144,312 | $86,858 |
| Other Inv. Act. | -$1,005 | -$183 | $0 | $4,006 |
| Investing Cash Flow | $123,358 | $35,042 | $28,269 | -$43,183 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $5 | $38 | -$178 | -$381 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | -$559 | $783 |
| Financing Cash Flow | $5 | $38 | -$178 | $402 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $45,979 | -$2,613 | -$6,796 | -$82,406 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $62,334 | $64,947 | $71,743 | $153,582 |
| End Cash | $108,313 | $62,334 | $64,947 | $71,743 |
| Free Cash Flow | -$78,488 | -$38,258 | -$35,517 | -$40,360 |